VitD CKD Prevalence Study - VitDCKD
Research type
Research Study
Full title
Prevalence of Vitamin D Deficiency in Adults with Stage 3 Chronic Kidney Disease in Two UK Regions: A Cross Sectional Observational Study
IRAS ID
351182
Contact name
Sharon Huish
Contact email
Sponsor organisation
Royal Devon University Healthcare NHS Foundation Trust
Duration of Study in the UK
1 years, 3 months, 1 days
Research summary
This study will measure how common vitamin D deficiency is in adults in the UK who have stage 3 chronic kidney disease (CKD).
Vitamin D is important for bone, muscle, and general health. People with CKD often have low vitamin D levels. Vitamin D deficiency can contribute to weak bones, muscle problems, and other health complications. In the UK, people with early-stage CKD are not routinely tested or treated for vitamin D deficiency. Reliable information on how common vitamin D deficiency is in people with stage 3 CKD in the UK is currently limited. This information is needed to design future research studies.
The study will take place in general practices in Devon and Leicestershire. We plan to recruit 240 adults who have stage 3 CKD. People who agree to take part will attend once to provide a single blood sample. The blood sample will be used to measure vitamin D and related blood markers. Basic information will also be collected from GP medical records.
The study does not involve any treatment or change to usual care.
The results will show how common vitamin D deficiency is in people with stage 3 CKD. These results will be used to plan a future clinical trial to test whether treating vitamin D deficiency improves health outcomes in this group.
REC name
West Midlands - Edgbaston Research Ethics Committee
REC reference
26/WM/0094
Date of REC Opinion
15 May 2026
REC opinion
Favourable Opinion